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ABSTRACT 
 
SEMA-1A REVERSE SIGNALING PROMOTES MIDLINE CROSSING IN RESPONSE 
TO SECRETED SEMAPHORINS 
 
Melissa Hernandez-Fleming 
 
Greg Bashaw 
 
For the majority of axons, an essential step in proper guidance involves crossing the 
midline, and failure to do so often results in an inability to coordinate movement. 
Attraction to the midline depends in part on the highly conserved guidance receptor 
DCC, or Frazzled in Drosophila, which signals chemoattraction upon binding its ligand, 
Netrin. DCC mutations in humans are associated with mirror movement disorder, an 
inability to independently control the right and left sides of the body. Although 
Frazzled/Netrin signaling is required for many axons to cross the midline, netrin and 
frazzled/DCC mutants still exhibit significant midline crossing, implicating additional pro-
crossing mechanisms. The Drosophila embryonic midline provides an ideal model to 
investigate nervous system development in vivo as it is genetically tractable and axon 
guidance cues are highly conserved. To identify additional pro-crossing pathways, we 
initiated a screen for modulators of midline crossing in a sensitized genetic background 
wherein Frazzled signaling is partially disrupted. Axon crossing defects in this 
background are enhanced by mutations in the transmembrane semaphorin, Sema-1a. 
Mutations in sema-1a also dominantly enhance crossing defects in a netrin mutant, 
indicating that Sema-1a functions in a Netrin independent pathway to promote midline 
crossing. Here we identify the transmembrane Semaphorin, Sema-1a, as a novel 
regulator of midline crossing in the Drosophila CNS. We show that Sema-1a functions as 
a receptor in response to the secreted Semaphorins, Sema-2a and Sema-2b, to promote 
midline crossing. In contrast to other examples of reverse signaling where Sema1a 
triggers repulsion through Plexin binding, in commissural neurons Sema-1a acts 
independently of Plexins to inhibit Rho and promote attraction to the midline. These 
findings suggest that Sema-1a reverse signaling can elicit distinct axonal responses 
depending on differential engagement of ligands and signaling effectors. 
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CHAPTER 1: SEMAPHORIN REVERSE SIGNALING: 
DEVELOPMENT AND BEYOND 
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1.1 Transmembrane Semaphorins: Key Family Members 
 
Semaphorins are ancient signaling molecules that are highly conserved and 
have been shown to play important roles in a diverse array of biological 
processes. First identified by their ability to direct axons at the growth cone 
(Kolodkin et al., 1992; Luo et al., 1993), they have since been found to influence 
a wide range of events from organ formation to immune responses (Shi et al., 
2000; Toyofuku et al., 2004b; Yazdani and Terman, 2006). In general, 
semaphorins act to modulate cell shape and mobility, allowing cells to respond to 
their changing environment. For this reason, there is a wealth of evidence for 
semaphorins serving vital functions during growth and development. These 
developmental activities are involved again in many diseases such as cancer and 
neurodegeneration where cells undergo renewed growth and motility or lack 
thereof (Pasterkamp and Roman J. Giger, 2009; Rehman and Tamagnone, 
2013). Outside of development, semaphorins can regulate the mobility of 
immune cells and sculpt synapses.  Given their involvement in these broad 
reaching activities it is no doubt that there are a multitude of mechanisms at their 
disposal. 
The semaphorin signaling family, as a whole, is large and varied. Family 
members take many forms and can be found as secreted, transmembrane, or 
membrane tethered molecules. All semaphorins share a defining feature called 
the Sema domain in the extracellular portion of the protein. The Sema domain is 
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roughly 500 amino acids and forms a seven blade β propeller fold that resembles 
integrins (Gherardi et al., 2004). This Sema domain is required for binding and 
signaling (Koppel et al., 1997; Tamagnone et al., 1999). Nearly all semaphorins 
also contain a cysteine rich domain (CRD), also called the PSI (present in 
Plexins, Semaphorins and Integrins) domain, immediately C-terminal to the 
Sema domain. Only some viral semaphorins lack this domain. The PSI domain is 
essential for dimerization (Klostermann et al., 1998).  
Semaphorins are divided into 8 classes based on structural features and 
species of origin. Classes 2 and 3 are comprised of the secreted variants from 
invertebrates and vertebrates, respectively.  The transmembrane semaphorins 
constitute the majority of the semaphorin family and include classes 1, 4, 5 and 
6.  Membrane tethered semaphorins make up the class 7 semaphorins. The final 
class of semaphorins is virally derived and considered class V semaphorins. This 
review will focus on only the transmembrane classes. 
 Semaphorin signaling has traditionally involved receptor complexes that 
include Plexin receptors as the signal-transducing partner. However, 
semaphorins have been shown to bind non-Plexin receptors as well.  In fact, the 
majority of secreted semaphorins do not bind directly to Plexin receptors and 
instead bind a Neuropilin co-receptor (Feiner et al., 1997). Studies show that 
semaphorins can exert a diversity of cellular responses based on the distinct 
combination of molecules in their receptor complex. 
 
	4	
 The overwhelming majority of semaphorin signaling events result in a 
chemorepulsive output or retraction response.  Initial characterization of 
semaphorins revolved around semaphorin induced growth cone collapse.  This 
response came to typify semaphorins signaling, however, cases of attraction and 
adhesion are beginning to come to light (Bagnard et al., 1998; Hsieh et al., 2014; 
Sun et al., 2015; Wolman et al., 2004; Wu et al., 2011). 
A growing number of studies have identified transmembrane semaphorins 
functioning as receptors to mediate cellular responses; this is termed “reverse 
signaling” while traditional signaling through a Plexin receptor is referred to as 
“forward signaling”. Although, this bi-directionality has not been identified in all 
transmembrane semaphorins it is likely to be a function shared by most. This 
review will focus predominantly on reverse signaling, but will also address 
forward signaling where it provides particular insight.  As it is, most cases of 
reverse signaling occur in tissues where forward signaling is also known to 
function. For this reason, it has been difficult to isolate the role of reverse 
signaling.  
Class 1 Semaphorins 
The class 1 semaphorins are only found among invertebrates and have the 
most homology with the class 6 vertebrate semaphorins (Yazdani and 
Terman, 2006). Class 1 semaphorins are best characterized in Drosophila. 
Their cytoplasmic regions are relatively short (~200 amino acids) and contain 
no recognizable functional domains (Kolodkin et al., 1993). There is very 
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strong conservation between class 1 semaphorins amongst Drosophila with 
cytoplasmic regions of high identity across species, but further work is still 
required in order to attribute any functionality to these conserved regions. 
Recent work from Jeong, et al., has identified an important binding site 
located in one of these conserved domains of Sema-1a in Drosophila.  This 
binding site was found to bind downstream effectors that regulate the Rho 
GTPase. Both a positive (RhoGEF) and a negative (RhoGAP) regulator of 
Rho compete for this cytoplasmic binding region (Jeong et al., 2012). Two 
other binding motifs have been identified in Sema-1a’s cytoplasmic domain a 
putative Enabled binding motif (LPQP) and a PDZ binding motif (VYL) 
(Godenschwege et al., 2002). As there are no invertebrate Neuropilins, both 
transmembrane and secreted semaphorins bind directly to Plexins. However, 
studies have shown alternative binding partners and Plexin independent 
functions particularly when signaling in reverse (Jeong et al., 2012; Sweeney 
et al., 2011). There are a growing number of studies that have documented 
reverse signaling through Drosophila Sema-1a, many of which will be 
discussed further. There have been no reports of the other Drosophila 
transmembrane Sema-1b functioning in reverse. 
Class 4 Semaphorins 
The class 4 semaphorins comprise the largest group of transmembrane 
semaphorins and include seven members, Sema4A-G. They are found only in 
vertebrates and have been found to function in diverse contexts. Their 
cytoplasmic domains are more substantial than class 1 semaphorins and a 
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number of Sema4s have recognizable PDZ interaction motifs. Furthermore, 
this motif has been shown to promote interactions with PSD-95/SAP90, an 
essential synaptic scaffold protein of the postsynaptic density in at least 3 
different Sema4 proteins. Sema4C contains a PDZ domain binding motif 
(SSV) on its carboxyl terminal and has been demonstrated to bind multiple 
proteins with PDZ domains including PSD-95 (Inagaki et al., 2001), Norbin 
(Ohoka et al., 2001) and SEMCAP1/GIPC (Wang et al., 1999). However, in 
the case of SEMCAP1/GIPC, this interaction was found to control subcellular 
distribution. Sema4B (Burkhardt et al., 2005) and Sema4F (Schultze et al., 
2001) both require this C-terminal motif to bind PSD-95 in hippocampal 
neurons. Sema4D does not have a PDZ binding motif, but it has been found 
to interact with a protein tyrosine phosphatase (CD45) and a serine/threonine 
kinase in the immune system (Elhabazi et al., 1997; Herold et al., 1996). 
The majority of Sema4s have not been associated with Plexin binding and 
their receptors are unknown for the most part. Sema4D binds PlexinB1 
(Tamagnone et al., 1999) and PlexinB2 (Masuda et al., 2004), but it also 
binds a non-classical receptor, CD72, in the immune system (Kumanogoh et 
al., 2000).  Sema4A binds Neuropillin1 (Delgoffe et al., 2013) in the immune 
system, but also binds Tim-2 in the lymphocytes (Kumanogoh et al., 2002). 
There is evidence that Sema4D can function in a monomeric or homodimeric 
form and that homodimers are preferentially cleaved (Elhabazi et al., 2001).  
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Sema4D undergoes processing by ADAM17 and this cleavage is negatively 
regulated through binding to Lrig2 (Van Erp et al., 2015). 
Class 5 Semaphorins 
Class 5 semaphorins are found in both vertebrates (Sema5A and Sema5B) 
and invertebrates (Sema5C). They share a characteristic stretch of seven 
canonical type 1 thrombospondin repeats (TSRs) in their ectodomain. Class 5 
semaphorins are the only class of transmembrane semaphorins that have not 
been directly implicated in reverse signaling. Sema5A can bind PlexinB3 to 
induce chemorepulsion or a PlexinB3-Met receptor complex to induce 
chemoattraction, while other functions have unidentified binding partners 
(Artigiani et al., 2004). The TSRs of Sema5A are also essential for 
interactions with heparin sulfate proteoglycans (HSPGs) and chondroitin 
sulfate proteoglycans (CSPGs), which modify the response Sema5A elicits 
from attraction to repulsion respectively (Kantor et al., 2004). 
Class 6 Semaphorins 
Class 6 semaphorins are the second largest group of transmembrane 
semaphorins with four members Sema6A-D.  Sema6s have the longest 
cytoplasmic domains compared to the other transmembrane semaphorins 
(~400 amino acids). Their cytoplasmic domains are highly divergent even 
amongst other members of the same class yet they all contain proline rich 
motifs that are likely to interact with SH3 domains. Both human and mouse 
Sema6A can bind EVL (ena/VASP like protein) through their proline rich 
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zyxin-like domain (Klostermann et al., 2000).  The proline rich domain of 
Sema6B interacts with the SH3 domain of Src (Eckhardt et al., 1997). 
Sema6D binds the SH3 domain of Abl and Mena through its proline rich 
zyxin-like domain (Toyofuku et al., 2004b). These cytoplasmic interactions 
were strong indications that Sema6s could function in reverse and almost all 
of the Sema6s, save Sema6C, have been demonstrated to do so. 
 
Sema6s bind directly to their Plexin receptors and preferentially bind the 
PlexinAs. Sema6B has been shown to form homodimers and may undergo 
posttranslational modifications in some cells (Eckhardt et al., 1997). There is 
evidence that Sema6D is cleaved in vivo (Toyofuku et al., 2004b). 
 
1.2 	Differentiation, Migration and Maturation 
Myoblast Differentiation 
Sema4C Reverse signaling has been implicated in muscle development, 
although the binding partner for this signaling cascade remains unknown (Ko 
et al., 2005).  Ko and colleagues utilized a culture system of C2C12 murine 
myoblasts to demonstrate that Sema4C expression is specifically elevated 
during early stages of mouse skeletal muscle differentiation in vitro.  This 
increased Sema4C expression occurs when myoblasts form myotubes and 
precedes the terminal differentiation markers myoD and myogenin. After 
myotube formation, Sema4C mRNA and protein levels are reduced. This 
culture system reveals that Sema4C is required for this terminal differentiation 
step as myotube formation was inhibited upon Sema4C RNAi knockdown. 
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Treatment of cultured cells with the Sema4C ectodomain blocks myotube 
formation; this is likely due to a dominant negative effect, suggesting Sema4C 
functions cell autonomously. Additionally, Sema4C expression was up-
regulated in vivo during muscle regeneration after injury implicating a broader 
role for Sema4C induced differentiation.  
  Myocardial Cell Migration  
One of the first examples of semaphorin reverse signaling documented in 
vertebrates comes from studies in the chick heart. This is also one of the best 
examples of forward and reverse signaling functioning together. Heart 
chamber maturation is a fundamental step in cardiac development and 
disruptions to this process result in congenital heart defects (Epstein et al., 
2015). At this stage of development, the heart is a looped tube with 
endocardial cells lining the inside of the tube and myocardial cells forming the 
outer layer. Dynamic interactions between the endocardial and the myocardial 
cells lead to the formation of two distinct layers within the myocardium of the 
ventricular segment. An outer compact layer forms and expands through 
circumferential migration while an inner trabeculated layer is formed through 
perpendicular migration. This circumferential migration is a result of 
simultaneous forward and reverse signaling through Sema6D and PlexinA1 
since the cells that make up the compact layer express both Sema6D and 
PlexinA1. RNAi knockdown of either Sema6D, PlexinA1 or both resulted in 
decreased ventricle size and poor trabeculation (Toyofuku et al., 2004a). It is 
not clear how these signaling pathways are transduced simultaneously 
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especially given the fact that cis interactions between Sema6A and PlexinA4 
or PlexinA2 have been shown to result in inhibition of signaling (Haklai-
Topper et al., 2010; Sun et al., 2013; Suto et al., 2007).  
Myocardial cells in the trabeculated layer express only Sema6D and are 
therefore repelled by the PlexinA1 in the compact layer towards the 
endocardium.  Trabecular defects in the PlexinA1 knockdown embryos can 
be rescued by the ectodomain of PlexinA1 indicating that this trabeculation 
process is indeed mediated through the Sema6D binding PlexA1 as a ligand 
(Toyofuku et al., 2004b). Downstream effectors for this reverse signaling were 
also identified though a yeast two hybrid screen with multiple clones of Abl-
kinase recovered. The cytoplasmic domain of Sema6D contains two 
consensus motifs for SH3 domain binding (PXXP) through which it can bind 
Abl.  Co-immunoprecipitation experiments show an increase in Abl binding 
and phosphorylation upon treatment with PlexinA1. These experiments also 
revealed increased cleavage of Sema6D upon PlexinA1 treatment with an 
enrichment of Abl associated with the truncated Sema6D fragments 
suggesting proteolytic processing to downregulate reverse signaling.  In the 
absence of PlexinA1, Sema6D was found to associate with Mena 
(Mammalian Ena homologue) through a zyxin-like domain. This association 
with Mena is reduced with PlexinA treatment and results in increased 
phosphorylation of Mena. The biological relevance of this association is not 
known, but the negative regulation of Mena binding is thought to increase cell 
motility (Bear et al., 2000, 2002). 
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The trabeculated layer and the endocardial cells are separated by a thick mix 
called cardiac jelly. The ectodomain of Sema6D is cleaved and secreted into 
the cardiac jelly (Toyofuku et al., 2004b). This accumulation of secreted 
Sema6D prevents the migration of endocardial cells through forward signaling 
as endocardial cells express only PlexA1. Repulsive forward signaling in 
endocardial cells was mediated by a PlexinA receptor complex with Off-Track 
which is distinct from the forward signaling complex required for earlier 
cardiac tube bending via VEGF2 and PlexA1 (Toyofuku et al., 2004a).   
Sema6D plays multiple roles in cardiac formation first through forward 
signaling to facilitate the looping of the cardiac tube with a VEGF2/PlexinA1 
receptor complex.  This step in cardiac development is then followed by a 
less defined action of simultaneous signaling of both forward and reverse 
pathways to promote myocardial expansion of the compact layer. At the same 
time, reverse signaling promoted trabeculation, which in turn prevent 
migration of endocardial cells. Of note, Sema6D mutant mice do not display 
any heart defects like they do in the chick embryo. However, there are many 
instances in chick where expression patterns of Sema/Plexin molecules do 
not match their most closely related orthologue in mouse. 
Oligodendrocyte Maturation  
Oligodendrocytes are responsible for the myelination of neurons in the central 
nervous system.  In order to induce myelination oligodendrocytes must 
mature from proliferative oligodendrocyte precursor cells (OPCs) to immature 
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and mobile oligodendrocytes and finally to mature oligodendrocytes. The 
maturation of oligodendrocytes depends upon signals from neurons and 
astrocytes as well as intrinsic programs. Sema4D was found to be expressed 
exclusively in oligodendrocytes within the CNS and functions to control 
apoptosis through an autocrine mechanism (Yamaguchi et al., 2012).  
However, recent evidence for reverse signaling has been demonstrated for 
Sema6A.  
Sema6A plays an important role in oligodendrocyte maturation; its expression 
is very high in developing oligodendrocytes with a peak corresponding to 
myelination. Oligodendrocytes from Sema6A deficient mice fail to myelinate 
axons. Knock-out mice show a delay in oligodendrocyte maturation both in 
vivo and in vitro. However, the canonical binding partners, PlexinA2 and 
Plexin A4, do not display any oligodendrocyte defects. Oligodendrocyte 
cultures lacking Sema6A cannot be rescued by treatment with Sema6A 
ectodomain suggesting a requirement for reverse signaling (Bernard et al., 
2012). 
B-lymphocyte proliferation  
Sema4D is highly expressed in the immune system particularly in T-
lymphocytes and B-lymphocytes (Shi et al., 2000). Both Sema3 and Sema4D 
have been shown to block the migration of dendritic cells as secreted cues, 
but Sema4D can promote B-lymphocyte proliferation cell autonomously 
(Delaire et al., 2001; Granziero et al., 2003; Wang et al., 2001). Sema4D 
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reverse signaling was found to increase proliferation and lifespan in both 
healthy and leukemic B lymphocytes (Granziero et al., 2003).  PlexinB1 binds 
Sema4D with high affinity and may act as the ligand to trigger B-cell 
proliferation (Tamagnone et al., 1999). PlexinB1 is expressed by bone 
marrow stromal cells, follicular dendritic cells and activated T-cells.  These 
cells are abundant in the immune system and would provide ample signaling 
opportunity for Sema4D B-cells. Sema4D positive B-lymphocytes 
demonstrate increased proliferation when co-cultured with PlexinB1 
expressing cells. Although this appears to be an interaction for healthy B-
lymphocyte proliferation it may also mediate proliferation of malignant B-
lymphocytes (Granziero et al., 2003). 
1.3 Visual System  
Photoreceptors 
Sema-1a was found to function as a receptor in the development of the 
Drosophila visual system. Sema-1a is expressed on the growth cones of 
photoreceptor cells (R-cells).  While there are 8 different types of R-cells only 
R-cells 1-6 project to the superficial layer of the optic lobe called the lamina; 
R-cells 7 and 8 project to the deeper medulla layer. Sema-1a is required for 
this projection pattern (Cafferty et al., 2006). In the absence of Sema-1a, the 
photoreceptors (R-cells1-6) fail to recognize their target or elaborate their 
growth cones at the lamina. This phenotype can be rescued by restoring full-
length Sema-1a expression to all neurons. However, no rescue is achieved 
when a truncated Sema-1a lacking its cytoplasmic domain is expressed. This 
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indicates that Sema-1a requires its cytoplasmic domain and functions cell 
autonomously to guide R-cells 1-6 to terminate at the lamina. Furthermore, 
overexpression studies show that a full-length Sema-1a can induce 
hyperfasciculation amongst R-cells while the truncated Sema-1a could not 
(Cafferty et al., 2006).  This function was later found to require Sema-1a’s 
canonical binding partner, PlexinA (PlexA). RNAi knockdown and plexA 
mutants phenocopy the Sema-1a loss of function phenotype. Additionally, 
PlexA overexpression could also induce hyperfasciculation, and this could be 
suppressed by loss of sema-1a. Interestingly, overexpression of PlexA 
lacking its cytoplasmic domain also induced hyperfasciculation, further 
supporting the notion that Sema-1a was acting as a receptor for PlexA (Yu et 
al., 2010). Genetic interactions also indicate that sema-1a and plexA function 
in the same pathway and that putative downstream effectors Enabled or Abl 
are unlikely to contribute. Further studies demonstrated that negative 
regulation of Rho1 mediates the attractive response between axons since it 
decreases surface levels of the adhesive molecule FasII. Rho1 activity is 
negatively regulated by Moesin (Moe). Sema-1a and Moe genetically and 
physically interact. Activation and phosphorylation of Moe is increased upon 
Sema-1a reverse signaling. Knockdown or mosaic mutant analysis of both 
Moe and FasII demonstrate R-cell defects that phenocopy Sema-1a mutants 
(Hsieh et al., 2014).  This was the first demonstration of an attractive output 
for Sema-1a reverse signaling and a direct contrast to the forward signaling 
affect on FasII (Yu et al., 2000). 
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Laminar Neurons 
In the Drosophila visual system the photoreceptors that terminate in the 
lamina (R-cells 1-6) also induce the differentiation of their target neurons, the 
laminar neurons (L1-5). These first order interneurons then project into the 
deeper layers of the medulla (Clandinin and Zipursky, 2000). Sema-1a 
reverse signaling is important for directing L3 laminar neurons to the correct 
layer. L3 mistargeting defects were observed when using a mosaic analysis 
with a repressible cell marker (MARCM) strategy to analyze single L3 
neurons rendered homozygous mutant for Sema-1a in an otherwise 
heterozygous animal. These mistargeting defects where L3 neurons extended 
beyond their appropriate layer can be rescued with the expression of full-
length Sema-1a. A novel sparse labeling technique demonstrated that Sema-
1a expression is enriched on L3 growth cones during L3 targeting. Sema-1a 
functions cell autonomously to reshape the growth cones and restrict them to 
a single layer.  This growth cone retraction is triggered by PlexA, which acts 
as a repulsive cue. PlexA is expressed on tangential fibers and forms a 
repellant barrier (Pecot et al., 2013). N-cadherin (CadN), a classical adhesion 
molecule, was previously demonstrated to play a cell autonomous role in L3 
targeting (Nern et al., 2008).  However, genetic interactions between Sema-
1a and CadN suggest that Sema-1a reverse signaling functions in a parallel 
pathway than CadN signaling (Pecot et al., 2013).  Furthermore, this function 
is not limited to L3 neurons, instead Sema-1a repulsion and CadN homophilic 
adhesion function together to broadly restrict laminar neurons to a general 
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domain in the outer medulla. Consistent with this, Sema-1a and CadN are 
expressed on most laminar neurons and L1, L3 and L5 laminar neurons 
initially project to the same region before refining their termination to distinct 
layers.  Interestingly, L1 neurons were found to relay directional information 
similar to ON bipolar cells in the vertebrate retina (Borst et al., 2010).  
Direction Selective Ganglion Cells 
Semaphorin reverse signaling also plays an important role in the mouse 
visual system. In the vertebrate visual system, visual information is 
communicated from the photoreceptors to the bipolar cells within the outer 
plexiform layer where the information is processed laterally through horizontal 
cells (Wassle, 2004). Bipolar cells then synapse with the primary output 
neurons, the retinal ganglion cells (RGCs), within the inner plexiform layer, 
which is stratified by directional selectivity (Wei and Feller, 2011). RGCs exit 
the retina and form connections in the brain for higher order visual 
processing. One such region is the accessory optic system (AOS) where 
image stabilization occurs. The AOS induces eye movements called an 
optokinetic reflex (OKR) in response to retinal input to stabilize visual input. 
Retinal inputs from direction-selective retinal ganglion cells (DSGCs), both the 
on DGCs and a subset of the on-off DSGCs, target to the AOS.  When this 
innervation is disrupted it results in defective eye movements (Masseck and 
Hoffmann, 2009).  
 
	17	
The On DSGCs are the major contributing pathway to the AOS and they 
express the transmembrane Sema6A.  Sema6A mutant mice exhibit defects 
in the DSGCs axon trajectory to the AOS and OKR behavior. PlexA2 and 
PlexA4 are known binding partners for Sema6A. Neither Plexin is expressed 
in the DSGCs, but both are present in the target tissue. A similar AOS 
phenotype was not identified in single Plexin mutants (for either PlexA2 or 
PlexA4); however, the double mutants phenocopy Sema6A. Cultured retinal 
explants also suggest that the Sema6A reverse signaling output is likely 
attractive rather than repulsive, which is consistent with the expression 
pattern (Sun et al., 2015).   
Unlike in Drosophila, there is no evidence that sema reverse signaling is 
involved in photoreceptor projections; however, forward signaling has been 
implicated in layer specificity (Matsuoka et al., 2011, 2012; Sun et al., 2013).  
1.4 Olfactory System  
Projection Neurons 
Sema-1a reverse signaling is involved in establishing the spatial organization 
in the olfactory system. Sema-1a functions as a receptor in the projection 
neurons (PNs) to direct both PN dendrites and PN axons to their appropriate 
targets. PNs send their dendrites to the antennae lobe in order to synapse 
with olfactory receptor neurons (ORNs) at discrete functional domains called 
glomeruli.  These glomeruli act as organizing centers for segregating ORNs 
by odor receptor type. Sema-1a expression is distributed throughout the 
 
	18	
antenna lobe in a graded fashion with the highest concentration in the 
dorsolateral region. This pattern is established by the PNs themselves and 
the PNs with the highest level of Sema-1a target to the most dorsolateral 
glomeruli.  Loss of Sema-1a leads to dendrite and axon mistargeting, which 
can be rescued cell autonomously with full-length Sema-1a. A Sema-1a 
transgene without the cytoplasmic domain fails to rescue these defects in 
either dendrites or axons. Overexpression of Sema-1a in PNs results in a 
directional shift toward the dorsolateral zone of the antenna lobe (Komiyama 
et al., 2007). This targeting is achieved through the repulsive action of Sema-
1a reverse signaling in PNs in response to an opposing gradient of the 
secreted Sema-2s. Sema-2a and Sema-2b are expressed in overlapping 
patterns and function redundantly to repel Sema-1a expressing PNs. Sema-
2a and Sema-2b single mutants lack PN defects, yet the double mutants 
display significant mistargeting errors. This interaction is likely to be indirect 
since physical interactions between Sema-1a and Sema-2a or Sema-2b could 
not be demonstrated. However, Sema-1a can bind in vivo to tissue 
overexpressing Sema-2a. The source of the secreted Sema-2s appears to be 
the degenerating larval ORNs. Complete ablation of these larval ORNs or 
RNAi knockdown of Sema-2s in larval ORNs both lead to a ventromedial shift 
in dorsolateral projecting PNs.  Furthermore, the PN mistargeting defects in 
Sema-2a, Sema-2b double mutants could be rescued by overexpression of 
Sema-2a in the larval ORNs (Sweeney et al., 2011). 
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1.5 Motor Neuron Development 
Motor Axon Defasciculation 
Motor axon pathfinding in the Drosophila embryo requires both forward and 
reverse Sema-1a signaling. Sema-1a mutants exhibit motor neuron 
defasciculation defects, which are only partially rescued with the expression 
of the ectodomain alone. Pebble (pbl) and RhoGAPp190 (p190) were 
identified as potential downstream effectors of Sema-1a reverse signaling 
through their physical association with Sema-1a’s cytoplasmic domain. Both 
Pbl and p190 regulate the small GTPase Rho1, yet they do so in opposing 
ways. Pbl positively regulates Rho1, while p190 negatively regulates Rho1.  
Structure function analysis indicates that the two downstream effectors 
competitively bind to the same region of the cytodomain. In vitro assays using 
Drosophila cells provided insights into the functional response of Sema-1a 
reverse signaling. In cultured cells, overexpression of Sema-1a or pbl results 
in a reduction in cell size, which is enhanced when both are overexpressed. 
However, this reduced cell size effect is lost if Rho1 is knocked down. In 
contrast, p190 overexpression leads to the opposite effect and cell size is 
increased. Mutations in pbl or RNAi knockdown leads to defasciculation and 
target recognition defects in motor neurons that are rescued when Pbl is 
expressed panneurally. Loss of p190 also disrupts motor neuron pathfinding, 
but with a distinct premature branching defect that is rescued upon panneural 
expression.  To link these downstream effectors to Sema-1a reverse 
signaling, the authors examined genetic interactions. Dominant interactions 
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between pbl and sema-1a revealed a positive functional relationship while 
p190 acted to antagonize Sema-1a reverse signaling. Further supporting this 
functional relationship, combined overexpression of Sema-1a and Pbl in all 
neurons leads to central nervous system defects only when Sema-1a’s 
cytoplasmic domain is in tact. 
Boundary Cap Cell Aggregation 
The separation between the central nervous system and the peripheral 
nervous system is maintained during development through a population of 
cells called the boundary cap cells.  This cluster of cells forms a temporary 
structure at the dorsal root entry zone (DREZ) and the ventral motor axon exit 
point (VMEP). When this structure is lost it results in the migration of motor 
neurons from the spinal cord. Sema6A reverse signaling is required to 
prevent this motor neuron exit. Sema6A is highly expressed in the boundary 
cap cells and these cells fail to cluster in the absence of Sema6A. Motor 
neurons expressing PlexinA1 are not repelled from Sema6A in culture.  
Instead, the boundary cap cells require Sema6A as a receptor to cluster 
appropriately by recognizing PlexinA1 on motor neurons as a stop signal 
(Mauti et al., 2007).  
 
1.6 Midline 
Post-crossing 
During the development of the chick central nervous system axons from 
commissural neurons cross the midline at the floor plate and make a rostral 
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turn. Axons continue to travel rostrally along the longitudinal aspect of the 
spinal cord. Sema6B reverse signaling is required in commissural neurons in 
order to make this rostral turn post crossing. When Sema6B is knocked down 
commissural neurons incorrectly navigate after exiting the floor plate. The 
majority of axons stalls and fails to turn completely while others turn caudally. 
This guidance step coincides with the transient expression of Sema6B in 
dorsal commissural neurons. Knockdown defects can be rescued with a full-
length Sema6B that is resistant to knockdown. However, Sema6B without its 
cytoplasmic domain fails to rescue suggesting Sema6B mediates this post-
crossing guidance through reverse signaling. The binding partner for Sema6B 
within the floor plate was identified as PlexinA2. Cell-binding assays and co-
immunoprecipitation experiments demonstrate a physical interaction between 
the two proteins. Additionally, selective knockdown of PlexinA2 in the floor 
plate leads to similar post-crossing defects. These axon guidance defects are 
rescued with both the full length and truncated forms of PlexinA2 injected 
specifically into the floorplate. Primary cell culture of commissural neurons 
show enhanced growth on substrate coated with PlexinA2 indicating that 
Sema6B initiates an outgrowth response to PlexA2. Interestingly, loss of 
PlexinA2 and PlexinA4 from commissural neurons also results in axon 
guidance defects in commissural neurons after crossing. This finding is 
similar to what had been previously demonstrated for forward signaling at the 
mouse midline (Charoy et al., 2012; Nawabi et al., 2010). Overexpression of 
PlexinA2 in commissural neurons leads to a premature stalling phenotype 
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suggesting that forward signaling is required post-crossing, and that it must 
be negatively regulated pre-crossing. Due to the co-expression of Sema6B 
and PlexinA2 in the commissural neurons, the authors speculate that 
Sema6B may negatively regulate forward signaling through cis interactions 
(Andermatt et al., 2014).  Futile cis interactions between Sema6s and their 
Plexin receptors have been previously demonstrated in the mouse retina (Sun 
et al., 2013)and sensory neurons of the dorsal root ganglia (Haklai-Topper et 
al., 2010). 
1.7 Synaptogenesis 
Presynaptic 
The Giant Fiber system is Drosophila is a well defined circuit that controls the 
jump-and-flight reflex. This circuit consists of a giant interneuron that sends a 
single giant axon fiber (GF) from the brain and makes a monosynaptic 
connection with a motorneuron (TTMn) for the jump muscle (tergotrochanteral 
muscle:TTM). In Sema-1a mutants this GF often fails to properly navigate to 
its motor neuron target. However, this guidance step is mediated by forward 
signaling and the expression of the Sema-1a ectodomain can rescue these 
defects when expressed either presynaptically in the GF or postsynaptically in 
TTMn. Surprisingly, the functionality of the synapse appears to be very 
sensitive to Sema-1a reverse signaling. Overexpression of Sema-1a 
presynaptically, but not postsynaptically, has a destabilizing effect on the 
synapse resulting in retraction of the GF terminal. Overexpression of the 
Sema-1a ectodomain fails to induce this effect. Moreover, this function can be 
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mapped to a specific motif within the cytoplasmic domain. Deletion of a 
putative Enabled binding motif (LPQP) abolishes this activity and 
heterozygosity of Enabled suppresses it; this suggests Enabled may be 
functioning downstream of this Sema-1a reverse signaling.  
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CHAPTER 2: SEMA-1A REVERSE SIGNALING PROMOTES 
MIDLINE CROSSING IN RESPONSE TO SECRETED 
SEMAPHORINS 
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2.1 Abstract 
	
Commissural axons must cross the midline to form functional midline circuits. In 
the invertebrate nerve cord and vertebrate spinal cord, midline crossing is 
mediated in part by Netrin-dependent chemoattraction. Loss of crossing, 
however, is incomplete in mutants for Netrin or its receptor Frazzled/DCC, 
suggesting the existence of additional pathways.  We identified the 
transmembrane Semaphorin, Sema-1a, as a novel regulator of midline crossing 
in the Drosophila CNS. We show that in response to the secreted Semaphorins 
Sema-2a and Sema-2b, Sema-1a functions as a receptor to promote crossing in 
parallel to Netrin. In contrast to other examples of reverse signaling where 
Sema1a triggers repulsion through activation of Rho in response to Plexin 
binding, in commissural neurons Sema-1a acts independently of Plexins to inhibit 
Rho and promote attraction to the midline. These findings suggest that Sema-1a 
reverse signaling can elicit distinct axonal responses depending on differential 
engagement of ligands and signaling effectors. 
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2.2 Introduction 
	
The ability to coordinate the right and left sides of the body relies heavily on 
intricate circuits within the midline.  Disruptions to these midline circuits during 
development, or after injury, often result in an inability to coordinate movement 
(Engle, 2010).  For the majority of midline circuits, appropriate circuit formation 
requires axons to cross the midline. Netrin and its attractive receptor DCC, or 
Frazzled (Fra) in Drosophila, are highly conserved guidance factors known to 
promote midline crossing (Harris et al., 1996; Kennedy et al., 1994; Kolodziej et 
al., 1996; Neuhaus-Follini and Bashaw, 2015a; Serafini et al., 1994). Loss of 
function mutations in this receptor have been associated with movement 
disorders in zebrafish, mice and humans(Jain et al., 2014; Rabe Bernhardt et al., 
2012; Srour et al., 2010). Despite this strongly conserved role in midline axon 
guidance, many axons still cross the midline in both netrinAB double mutants 
(hereafter referred to as netAB) and fra mutants in Drosophila, suggesting that 
there must be additional pathways to promote midline crossing (Kolodziej et al., 
1996; Mitchell et al., 1996).  Studies in vertebrate systems have yielded a few 
promising leads for pathways contributing to midline crossing, such as Shh/Boc 
(Charron et al., 2003), VEGF/Flk1(Ruiz de Almodovar et al., 2010), and 
Sema/Plexin (Nawabi et al., 2010; Zou et al., 2000).  Unfortunately, redundancies 
in both ligands and receptors have led to ambiguous results when trying to 
discern molecular mechanisms from mutant phenotypes (Charoy et al., 2012; 
Delloye-Bourgeois et al., 2014; Hernandez-enriquez et al., 2015; Parra and Zou, 
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2010; Sloan et al., 2015). In order to identify additional pathways in a more 
tractable system, we developed a genetic modifier screen where Fra signaling is 
specifically reduced in a small subset of commissural neurons in the Drosophila 
embryo. By screening a library of chromosomal deletions for enhanced crossing 
defects, we identified the transmembrane semaphorin, Sema-1a, as novel 
regulator of midline crossing.  
Semaphorin/Plexin signaling is highly conserved and has been shown to play 
many roles within the nervous system. In vertebrates, the Sema/Plexin family of 
signaling molecules is large and diverse; while in Drosophila, Semas and Plexins 
constitute a fairly small family. There are five semaphorins identified in 
Drosophila and only two Plexins.  Semas are divided into two classes: 
transmembrane (Sema-1a, Sema-1b and Sema-5c) or secreted (Sema-2a and 
Sema-2b)(Pasterkamp, 2012). Neither Sema-1b nor Sema-5c show neural 
expression in the developing CNS, though they are highly enriched in embryonic 
ectoderm and mesoderm, respectively (Khare et al., 2000). The transmembrane 
Semas bind Plexin A (PlexA), while Plexin B (PlexB) binds the secreted Semas 
(Ayoob et al., 2006; Winberg et al., 1998). In the fly, Sema-1a is known to act as 
a repulsive/de-adhesive signal during motor axon guidance (Jeong et al., 2012; 
Yu et al., 1998a, 2000).  A broader role within the CNS, however, is not 
surprising since the expression patterns of Sema-1a and PlexA both appear to 
be pan-neural and the longitudinal connectives within the CNS show defects in 
both sema-1a and plexA mutants (Kolodkin et al., 1993; Winberg et al., 1998). In 
fact, it has been proposed that repulsive Sema-1a/PlexA signaling may act as an 
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organizing factor at the midline to restrict sensory afferents to more ventral 
positions of the neuropil (Zlatic et al., 2009). Still, a role for Sema-1a in 
commissure formation has never been explored. In vertebrates, secreted Semas 
are important for commissure formation because they repel crossing axons from 
the floorplate (Jongbloets and Pasterkamp, 2014; Nawabi et al., 2010; Zou et al., 
2000). The expression pattern of Sema-1a, however, precludes a similar function 
in fly. Intriguingly, a growing body of evidence has demonstrated that Sema-1a 
can signal in both a forward direction as a ligand and in reverse as a receptor 
itself. Sema-1a reverse signaling can occur through PlexA binding, as observed 
in the visual system and the giant fiber circuit (Cafferty et al., 2006; 
Godenschwege et al., 2002; Pecot et al., 2013)or through indirect interactions 
with other secreted Semas as shown in the olfactory system (Komiyama et al., 
2007). In other cases, such as during the guidance of Drosophila motor axons, 
Sema-1a appears to act independently of Plexin and the ligand is not known 
(Jeong et al., 2012). 
In this study, we find that Sema-1a promotes midline crossing in parallel to 
Netrin/Frazzled chemoattraction. Sema-1a mediates this function cell 
autonomously in commissural neurons. A region of Sema-1a’s cytodomain 
previously shown to bind Pebble and RhoGAP190 is required for Sema-1a to 
promote crossing. In addition, RhoGAP190 and the downregulation of Rho1 are 
important for midline crossing. Surprisingly, Sema-1a's canonical binding partner, 
PlexA, does not contribute to Sema-1a’s pro-crossing function. Instead, the 
secreted Sema2s confer signaling cues. Taken together, these data are 
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consistent with a model where Sema-1a mediates midline crossing through an 
attractive/adhesive mechanism via RhoGAPp190 in response to secreted 
semaphorins at the midline. 
2.3 Materials and Methods 
	
Genetic Analyses  
The following Drosophila mutant alleles were used: fra3, fra4 ,fra6, netAB, 
egMZ360 (eg-GAL4), slit2, robo-1GA285. The following flies were obtained from the 
Bloomington Stock Center: sema-1aP1, plexin A EY16548, plexin BKG00878 , pbl2, and 
Rho172F.  The following stocks were kind gifts from A. Kolodkin: sema-2aB65 (Wu 
et al., 2011), sema-2bC4(Wu et al., 2011), sema-2abA15(Wu et al., 2011), and 
p1902 (Jeong et al., 2012).  The sema-1a artificial exon was a kind gift from L. 
Zipursky. The following transgenes were used: UAS-Fra∆C (Garbe et al., 2007), 
UAS-sema-1aFL, UAS-sema-1a∆31-60, UAS-sema-1aECFC (Jeong et al., 
2012), UAS-FLP recombinase, UAS-26XLexAopmyrGFP, UAS-mycp190, UAS-
RhoN19. GAL4 drivers used were elav-GAL4 and eg-GAL4.  All crosses were 
carried out at 25˚C. Embryos were genotyped using balancer chromosomes 
carrying lacZ markers or by the presence of epitope-tagged transgenes. 
Immunofluorescence and imaging 
Dechorionated, formaldehyde-fixed, methanol devitellinized embryos were 
fluorescently stained as previously described (Kidd et al., 1998). The following 
primary antibodies were used in this study: mouse anti-1D4/FasII [Developmental 
Studies Hybridoma Bank (DSHB); 1:100], mouse anti-Beta gal [DSHB; 1:150], 
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mouse anti-Robo [DSHB; 1:50], mouse anti-Myc [DSHB (9E10); 1:500] rabbit 
anti-GFP [Invitrogen( #A11122); 1:500], mouse mAb anti-V5 [Serotec; 1:200], 
Mouse anti-HA [Covance (16B12) 1:250], Alexa647-conjugated goat anti-HRP 
[1:500, Jackson Immunoresearch (#123-605-021); 1:500]. Cyanine 3-conjugated 
goat anti-rabbit [Jackson; 1:1000], Alexa488-conjugated goat anti-mouse 
[Molecular Probes; 1:500] were used as secondary antibodies.  Stage selected 
embryos were filleted to reveal the CNS from the dorsal side and mounted in 
70% glycerol/PBS. Images were acquired using a spinning disk confocal system 
(PerkinElmer) built on a Nikon Ti-U inverted microscope using a Nikon OFN25 
60X or 40X objective with a Hamamatsu C10600-10B CCD camera and 
Yokogawa CSU-10 scanner head with Volocity imaging software. Images were 
processed using ImageJ.  
Phenotypic Quantification 
For EW commissural neuron crossing phenotypes, whole-mount or filleted 
embryos were analyzed at Stages 15 and 16. Eight abdominal segments were 
analyzed per embryo where possible, and for each embryo, the percentage of 
non-crossing segments was calculated. A segment was considered non-crossing 
when both clusters of EW axons (six axons per segment) failed to reach the 
midline. For quantification of phenotypes using HRP, both posterior and anterior 
commissures were scored. A commissure was considered absent if it was not 
continuous or distinguishable from the other commissure in the segment.  
Commissures were thin/defective if they were substantially thinner than in wild-
type (WT) embryos or excessively defasciculated. For statistical analysis, 
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comparisons were made between genotypes using the Student’s t-test. 
 
2.4 Results 
	
A genetic screen identifies Sema-1a as a factor that promotes midline 
crossing  
In order to identify molecules that function to promote midline crossing, we 
performed a genetic screen using a truncated Fra receptor (Fra∆C) lacking its 
cytoplasmic domain, that functions as a dominant negative (Garbe et al., 2007). 
By specifically expressing Fra∆C in a small subset of commissural neurons, the 
eagle neurons, we were able to establish a highly sensitized background. The 
eagle neurons are grouped into two clusters per hemisegment, the EGs and 
EWs. Approximately ten EG neurons project their axons through the anterior 
commissure, while only three EW neurons project their axons through the 
posterior commissure (Higashijima et al., 1996)(Figure 2.1A). These neurons can 
be easily identified and manipulated with eg-Gal4 and have been found to rely on 
Netrin/Fra chemoattraction. In netAB mutants or fra mutants, the EW neurons 
show a marked decrease in midline crossing, while the EG neurons are 
unaffected (Garbe et al., 2007).  These defects can be easily quantified by 
calculating the fraction of abdominal segments where EW neurons fail to cross 
the midline. In fra mutants the EW axons fail to cross the midline in 
approximately 34% of abdominal segments, and expressing FraΔC specifically in 
the eagle neurons of an otherwise wild-type embryo results in a similar 
phenotype (Figure 2.1B, C, G). We screened large deficiencies covering a 
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majority of the second chromosome and identified dominant enhancers of the 
Fra∆C crossing defects. This approach allowed us to identify even subtle 
crossing defects in heterozygous embryos and thus circumvent any obstacles 
like early gene requirement that would normally preclude many genes from 
examination. 
A deficiency on the second chromosome, DF(2L)ED623, enhances the Fra∆C 
phenotype to 49% (Figure 2.1G). The enhancer activity in this interval was 
genetically mapped to Sema-1a and a null allele, sema-1aP1, is able to fully 
recapitulate the enhanced EW defects observed with the deletion (Figure 2.1D, 
G). These crossing defects are dose dependent and are strongly enhanced when 
both copies of sema-1a are removed (Figure 2.1E, G).  Furthermore, this severe 
mutant phenotype can be robustly rescued when full-length Sema-1a (Sema-
1aFL) is restored selectively in the eagle neurons (Figure 2.1F, G). In order to 
validate the effects of sema-1a seen in the screen, we analyzed the genetic 
interaction between sema-1a heterozygotes and fra hypomorphs. Loss of one 
copy of sema-1a leads to an enhancement of EW neuron crossing defects in 
multiple hypomorphic backgrounds (Figure 2.3). This result further supports an 
endogenous role for sema-1a in promoting midline crossing.  
Sema-1a promotes midline crossing independently of Netrin/Fra 
chemoattraction 
To test whether Sema-1a functions together with, or independently of, Netrin/Fra 
chemoattraction, we examined genetic interactions between sema-1a and fra or 
NetAB mutants. The hallmarks of reduced midline crossing can be readily 
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observed when the entire axon scaffold is stained with anti-HRP antibodies. In 
wild-type embryos, thick commissures form in the anterior and posterior of each 
segment (Figure 2.2A). Both NetAB and fra null mutants display mild crossing 
defects, which are observed as thin or occasionally missing commissures (Figure 
2.2B and 2.3). Sema-1a null mutants, however, show no significant crossing 
defects in either the axon scaffold or the eagle neuron commissural subset 
(Figure 2.2C and data not shown).  If sema-1a were functioning in a parallel 
pathway to promote midline crossing, we would expect the loss of sema-1a to 
enhance the mild crossing defects seen in fra and NetAB mutants.  While 
embryos heterozygous for both fra and sema-1a display no defects, the double 
mutants have a very different phenotype (Figure 2.2D and E). When we examine 
sema-1a, fra double mutants, we see a strong enhancement in crossing defects 
compared to fra single mutants (total defects: sema-1a, fra = 92% vs. fra = 40%; 
Figure 2.2E) as well an increase in the number of missing commissures (missing: 
sema-1a, fra =68% vs. fra=10%; Figure 2.2E). The majority of sema-1a, fra 
double mutant embryos are nearly commissureless, and these defects can be 
directly attributed to the loss of sema-1a since double mutants can be robustly 
rescued with pan-neural expression of Sema-1aFL (total defects: 56%, missing: 
25%; Figure 2.2F). Furthermore, this dramatic double mutant phenotype is not 
specific to sema-1a, fra double mutants, as it is nearly identical to the phenotype 
of NetAB; sema-1a double mutants (total defects: NetAB, sema-1a = 71% vs. 
NetAB = 25%), again with the strongest increase in the number of missing 
commissures (missing: NetAB, sema-1a = 48% vs. NetAB = 6%; Figure 2.3).  
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To further support the argument that sema-1a acts independently of the 
Netrin/Fra pathway, we analyzed dominant genetic interactions in the eagle 
commissural neurons.  The crossing defects in both fra or NetAB mutants are 
significantly increased when a single copy of sema-1a is removed (Figure 2.3). 
These data demonstrate that Sema-1a must function independently of Netrin/Fra 
chemoattraction. We also explored the possibility that the effect of sema-1a on 
midline crossing could be due to up-regulation of Robo1 repulsion. We found that 
loss of sema-1a did not result in changes in Robo1 protein expression, nor does 
loss of sema-1a show genetic interaction with slit or robo mutants (Figure 2.4). 
Taken together, this evidence suggests that Sema-1a acts in parallel to 
Netrin/Fra and is unlikely to exert its pro-crossing effect through regulation of 
midline repulsion. 
 
Sema-1a is endogenously expressed in eagle commissural neurons 
during midline crossing 
	
Previously published expression data suggests that Sema-1a is expressed pan-
neurally and that Sema-1a protein can be detected throughout the ventral nerve 
cord including in axon commissures (Kolodkin et al., 1993; Yu et al., 1998a).  
Ablation studies have suggested that these Sema-1a positive cells are mostly the 
motor neurons and Gad positive interneurons (Zlatic et al., 2009). Our initial 
findings, specifically the pan-neural rescue of the sema-1a, fra double mutant, 
would suggest that Sema-1a is required in neurons to promote midline crossing. 
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However, it is still unclear in which neurons Sema-1a is acting to promote midline 
crossing, since it could function in the commissural neurons themselves or in 
surrounding neurons. To address this question, we wanted to first know if Sema-
1a is endogenously expressed in the eagle commissural neurons. Antibody 
staining and in situ hybridization techniques suggested co-localization with eagle 
neurons, but due to the broad expression of Sema-1a throughout the neuropil we 
are unable to adequately resolve individual neurons (data not shown). To 
definitively distinguish endogenous Sema-1a expression in a tissue specific 
manner, we took advantage of a genetically engineered fly line developed in the 
Zipursky lab that allows sparse labeling of endogenous Sema-1a (Pecot et al., 
2013). Pecot and colleagues generated an artificial exon within the endogenous 
locus carrying a conditional genetic tracer that allows us to visualize both the 
cells that express Sema-1a and the Sema-1a protein itself (Pecot et al., 2013).  
This dual visualization is achieved by the co-expression of a V5-tagged Sema-1a 
and a LexA transcription factor, which are restricted from expression by a stop 
cassette flanked by FRT sites (Figure 2.5A). Thus, tissue specific expression of 
FLP excises the stop cassette, allowing visualization of endogenous Sema-1a 
expression only in the tissue of interest.  Expression of FLP in eagle neurons 
resulted in an a mosaic expression during the time of midline crossing (Figure 
2.5B).  This sparse labeling allowed us to capture endogenous sema-1a 
expression at single cell resolution. Assessments across multiple embryos 
indicate that Sema-1a is indeed endogenously expressed in all eagle neurons 
including the EW cluster (Figure 2.5C’).  Visualization of Sema-1a molecules 
 
36	
using the V5 tag reveals a punctate pattern on cell bodies and strong labeling of 
the axons during the time when they are crossing the midline (Figure 2.5C”).   
 
Sema-1a functions cell autonomously, and its cytoplasmic domain is 
required for midline crossing 
Sema-1a is traditionally thought to act as a ligand for PlexA receptors, yet it has 
been demonstrated to function in reverse as a receptor itself (Cafferty et al., 
2006; Godenschwege et al., 2002; Hsieh et al., 2014; Jeong et al., 2012; 
Komiyama et al., 2007; Pecot et al., 2013; Sweeney et al., 2011).  Given the fact 
that Sema-1a is expressed in commissural neurons and appears to function in 
neurons to promote crossing, we wanted to explore if Sema-1a functions as a 
receptor in this context. To determine if Sema-1a promotes midline crossing 
through reverse signaling, we tested if Sema-1a’s cytoplasmic domain is required 
cell autonomously in commissural neurons. To address cell autonomy without 
introducing non-autonomous “follower effects,” we used a sema-1a mutant 
expressing the dominant negative Fra receptor (Fra∆C) in the eagle neurons 
only. These embryos display the same level of defects in the eagle neurons as 
sema-1a, fra double mutants, while the rest of the CNS appears largely wild-type. 
We compared the ability of full-length and two truncated Sema-1a transgenes to 
rescue crossing defects in this genetic background. These transgenes are 
targeted to the same genomic locus and are expressed at comparable levels. All 
three transgenes are capable of rescuing forward signaling yet only the full-
length transgene is able to completely rescue reverse signaling (Jeong et al., 
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2012). A robust rescue is achieved when the full-length Sema-1a transgene 
(Sema-1aFL) is restored to eagle neurons in this Fra∆C background, with eagle 
neuron crossing defects reduced from 98% to 26%  (Fig. 4 and Fig. 1). This 
would suggest a cell autonomous requirement since there is no Sema-1a present 
to function cell non-autonomously in this background. Furthermore, the truncated 
Sema-1a transgene (UAS-Sema-1a∆C) completely fails to rescue, suggesting 
that the cytoplasmic domain is required and that Sema-1a likely mediates midline 
crossing through reverse signaling. To further determine the region within the 
cytoplasmic domain that is necessary for midline crossing, we tested a third 
transgene (Sema-1a∆31-60) carrying a small deletion within the cytoplasmic 
domain, which removes amino acids 31-60. This cytoplasmic region includes the 
binding site for downstream effectors of Sema-1a reverse signaling in motor 
neurons and was demonstrated to physically interact with two opposing 
regulators of the small GTPase Rho1(Jeong et al., 2012).  Expression of this 
transgene results in a dramatically reduced rescue, implicating this region in 
midline crossing and further supporting the conclusion that Sema-1a promotes 
midline crossing through reverse signaling (Figure 2.6).  Although Sema-1a∆31-
60 does produce a small but significant reduction in crossing defects, it does not 
rescue crossing nearly as well as the full-length transgene.   
These findings in the eagle neurons are consistent with the pan-neural rescue of 
the sema-1a, fra double mutants. When we pan-neurally express these Sema-1a 
transgenes we get a similar rescue profile where Sema-1a-FL leads to a strong 
yet partial rescue, Sema-1a∆31-60 produces a blunted rescue, and Sema-1a∆C 
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completely fails to rescue (Figure 2.7). Notably, Sema-1a∆C does rescue forward 
signaling in other systems(Godenschwege et al., 2002; Jeong et al., 2012). If 
forward signaling were contributing to midline crossing directly, then we would 
expect a partial rescue with the Sema-1a∆C transgenes, yet this is not what we 
see in any genetic background. These data indicate that Sema-1a promotes 
midline crossing through reverse signaling since it functions cell autonomously 
and its cytoplasmic domain is required.  The results with the small cytoplasmic 
deletion also point to specific binding partners that may be important for 
mediating the downstream pathway involved in Sema-1a dependent midline 
crossing.  
 
RhoGAPp190 and the negative regulation of Rho1 are required for 
midline crossing  
A recent study identified Pebble RhoGEF (Pbl) and RhoGAPp190 (p190) as 
potential effectors of Sema-1a reverse signaling in Drosophila motor neurons 
(Jeong et al., 2012).  Both proteins bind the cytoplasmic region of Sema-1a, and 
both mutants display distinct defects in motor axon guidance. To investigate the 
roles of Pbl and p190 in midline crossing, we examined their genetic interactions 
with sema-1a and fra. Pbl and p190 are known to exert opposing effects on the 
actin cytoskeleton through regulation of the small GTPase, Rho1. Pebble 
positively regulates Rho1 and is proposed to function in concert with Sema-1a to 
produce a repulsive/de-adhesive response in motor neurons (Jeong 2012), while 
RhoGAPp190 acts as a negative regulator of Rho1 and has been demonstrated 
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to promote adhesion and branch stability (Billuart et al., 2001; Jeong et al., 
2012).  To investigate if these effectors modulate midline crossing downstream of 
Sema-1a, we examined whether heterozygosity for pbl or p190 mutations 
dominantly enhance crossing defects in the sensitized Fra∆C background.  
Heterozygosity for p190 does not significantly enhance crossing defects (46%; 
Figure 2.8). To test this finding further, we examined p190 zygotic null mutants in 
this background, and this produces a dramatic increase in crossing defects 
similar to sema-1a nulls in the same background (81%; Figure 2.8). 
Overexpression of p190 in the eagle neurons reduces the number of defects 
seen in Fra∆C background to 16% of abdominal segments (Figure 2.8). In 
contrast, heterozygosity for pbl did not result in an enhancement of crossing 
defects. Instead, it suppressed these defects to 10% (Figure 2.8).  We were 
unable to test pbl null mutants since pbl is required for cytokinesis, but we were 
able to evaluate their shared downstream target, rho1(Prokopenko et al., 1999). 
Reductions in rho1 lead to a similar suppression as pbl, where only 21% of eagle 
neurons fail to cross the midline.  Additionally, expression of a dominant negative 
Rho1 transgene specifically in the eagle neurons similarly suppresses crossing 
defects to 25%. This result is consistent with the hypothesis that Sema-1a 
promotes midline crossing through RhoGAPp190 and the down regulation of 
Rho1.  
The secreted semaphorins function to promote midline crossing  
In order to better understand the cellular mechanism of Sema-1a-mediated 
midline crossing, we next sought to determine which, if any, of the known extra-
 
40	
cellular binding partners of Sema-1a might act as a ligand for reverse signaling in 
commissural neurons. We would expect that any component of the Sema-1a 
mediated midline crossing pathway should phenocopy the strong sema-1a, fra 
double mutant phenotype. Importantly, embryos lacking both fra and plexA or 
plexB fail to phenocopy sema-1a, fra double mutants, and the crossing defects 
are not significantly different from fra mutants alone (Figure 2.9). These results 
strongly suggest that Plexins are not contributing to Sema1a-dependent midline 
crossing. In contrast, fra, sema-2a double mutants exhibit defects that resemble 
sema-1a, fra double mutants, and total defects are significantly enhanced 
compared to fra single mutants.  Although total crossing defects are comparable 
between the sema-2a, fra double mutants and the sema-1a, fra double mutants, 
there is a distinct shift in the profile of these defects. The majority of defects 
identified in fra, sema-2a double mutants are thin/defective commissures while 
sema-1a, fra double mutants primarily exhibit absent commissures (Figure 2.9).  
 One reason why the fra, sema-2a double mutants may fail to fully recapitulate 
the sema-1a, fra double mutants may be because of compensation by the other 
secreted semaphorin, Sema-2b.  Sema-2a and Sema-2b show 70% amino acid 
identity and have been demonstrated to function redundantly in certain tissues 
(Sweeney et al., 2011; Wu et al., 2011).  The secreted semaphorins are both 
expressed in the developing nerve cord at the time of commissure formation and 
both proteins are found to decorate the anterior and posterior commissures 
(Emerson et al., 2013; Kolodkin et al., 1993; Wu et al., 2011; Zlatic et al., 2009). 
Sema-2a, however, displays a distinct enrichment at the midline (Kolodkin et al., 
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1993; Wu et al., 2011). To test for a contribution of Sema-2b, we generated fra, 
sema-2a, sema-2b triple mutants.  However, commissural defects in these triple 
mutants are not significantly different from those seen in the fra, sema-2a double 
mutants (Figure 2.9).  Because it is difficult to capture subtle changes in 
commissural defects when examining the entire axon scaffold with HRP, we also 
evaluated fra, sema-2b double mutants in eagle neurons. We see a clear 
enhancement of crossing defects when sema-2b is lost (50%) compared to fra 
single mutants (27%).  This enhancement is not as robust as the enhancement 
seen in fra, sema-2a double mutants (75%; Figure 2.10).  The fra, sema2ab triple 
mutants display defects similar to the double mutants (58%).  
In order to more directly assess if Sema-1a mediates midline crossing in a PlexA 
or Sema-2 dependent manner, we examined the ability of UAS Sema-1a to 
rescue sema-1a-dependent crossing defects in the absence of either plexA or 
sema-2a.  If either gene is a required component of the Sema-1a pathway, the 
ability of UAS Sema-1a to rescue should be suppressed when plexA or sema-2a 
are also mutant. Therefore, we evaluated the degree of rescue when Sema-1a is 
expressed in a sema-1a;;plexA double mutant with Fra∆C in eagle neurons. 
Sema-1a is still able to rescue crossing in the absence of plexA, strongly arguing 
that Sema-1a mediated midline crossing is PlexA independent. However, Sema-
1a is not able to rescue to the same extent when expressed with Fra∆C in the 
eagle neurons of sema-1a, sema-2a double mutants (Figure 2.11). The 
incomplete suppression is likely due to compensation by Sema-2b. These data 
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would indicate that Sema-2a, and not PlexA, functions to instruct the Sema-1a 
mediated midline crossing pathway.   
 
2.5 Discussion 
	
These data demonstrate that Sema-1a represents a novel pathway for promoting 
midline crossing.  We find that Sema-1a not only functions as a receptor to 
promote midline crossing, but it does so independently of its canonical binding 
partner PlexA. Our genetic data suggest that the secreted Semas represent 
components of the Sema-1a ligand in this context. Furthermore, the spatial 
distribution of these components, as well as the known roles of the downstream 
effectors, suggest this Sema-1a signaling pathway results in an attractive or 
adhesive response, rather than the repulsive response that is typically associated 
with Sema/Plexin signaling. In most systems where Sema-1a reverse signaling 
has been identified, forward signaling has also been found to function. This 
bidirectional signaling has made it difficult to divorce the two signaling cascades 
and determine the distinct mechanism of Sema-1a reverse signaling. We find 
that specific genetic manipulations in a well defined tissue such as the ventral 
midline allow us to establish a system where the two pathways can be more 
clearly separated. In this way, we can begin to define the Sema-1a reverse 
signaling contribution to midline crossing.  
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Sema-1a functions in a novel pathway for promoting midline crossing 
By using a sensitized background and looking specifically at the tissue of 
interest, we were able to identify alternative pathways for promoting midline 
crossing. Sema-1a has never before been associated with midline crossing since 
the null mutants alone show no commissural defects. Analysis of mutants in the 
eagle neurons fails to show a significant reduction in crossing when Sema-1a is 
absent (data not shown). The effect of Sema-1a loss of function is only apparent 
when the major attractive pathway of Netrin/Fra signaling is removed. We 
observed this interaction in a number of different backgrounds, first with the Fra 
dominant negative (Fra∆C), as well as with the fra and netAB mutants, and then 
most dramatically with the sema-1a, fra or netAB; sema-1a double mutants.  
Our lab previously uncovered a netrin-independent role for Fra as well as a role 
for robo2 in promoting midline crossing (Evans et al., 2015; Neuhaus-Follini and 
Bashaw, 2015b; Yang et al., 2009). Both of these pathways appear to function by 
negatively regulating Robo1 repulsion at the midline. In order to understand how 
redundant/ convergent these pathways may be, we further explored the 
interactions between Sema-1a and known midline pathways. Genetic interactions 
reveal a clear parallel function between Fra/Netrin chemoattraction and Sema-
1a. Genetic interactions with robo1, slit double heterozygotes suggest that Sema-
1a does not function as another anti-repulsive mechanism (Figure 2.4). 
Additionally, Robo1 protein expression does not appear to be upregulated in 
sema-1a mutants (Figure 2.4). Taken together, our observations indicate that 
Sema-1a promotes midline crossing through an independent pathway. 
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Sema-1a mediates midline crossing through reverse signaling in 
commissural neurons  
Reverse signaling through transmembrane semaphorins has been demonstrated 
in both invertebrates and vertebrates, where the class 6 semaphorins show a 
particular similarity with Drosophila Sema-1a. The role of Sema6D in endocardial 
cell migration was the first in vivo demonstration of reverse signaling in 
vertebrates (Toyofuku et al., 2004b).  More recently, findings of semaphorin 
reverse signaling in neurons have revealed that class 6 semaphorins may have 
more axon guidance roles similar to those identified for Sema-1a reverse 
signaling in Drosophila.  A recent study in chick by Andermatt and colleagues 
demonstrated that Sema6B functions as a receptor in post-crossing commissural 
neurons potentially by promoting an outgrowth response (Andermatt et al., 2014). 
Evidence of a more instructional role for reverse signaling was found in a subset 
of On direction-selective ganglion cells (OnDSGCs).  Here, Sema6A mediates 
axonal targeting to the accessory optic system (AOS) through an attractive 
response to Plexin A2 and A4 (Sun et al., 2015).  Although it is clear that the 
capability of transmembrane semaphorins to signal in reverse and function as 
axon guidance receptors is highly conserved and that Sema/Plexin signaling 
participates in midline guidance, it had not been previously known whether Sema 
reverse signaling contributes directly to midline crossing until now.   
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RhoGAPp190 mediates Sema-1a reverse signaling to promote midline 
crossing 
In the majority of cases, Sema-1a reverse signaling promotes repulsive guidance 
in response to Plexins, yet there are attractive signaling outputs and binding 
partners as well. Two classes of neurons in the visual system, the laminar 
neurons and the photoreceptors were both found to employ Sema-1a reverse 
signaling and both bound the canonical binding partner PlexA; however, the 
laminar neurons exhibit a repulsive response to PlexA, while the photoreceptors 
show an adhesive response (Cafferty et al., 2006; Hsieh et al., 2014; Pecot et al., 
2013). This variable signaling output highlights the need to identify other pathway 
components that may regulate distinct functional responses. 
The discovery of competitive downstream effectors (Pbl and RhoGAPp190) with 
opposing effects on Rho1 began to explain how Sema-1a reverse signaling could 
have multiple, and even opposite outputs. This competition introduces one level 
of regulation and we speculate that there are additional regulators that function to 
modulate the activity of these effectors and the ultimate axonal response.  For 
instance, Src family kinases, which phosphorylate p190 within the GTP binding 
domain, leading to inhibition of p190 activity (Billuart et al., 2001; Brouns et al., 
2001; Roof et al., 2000) may act to modulate Sema-1a reverse signaling. Indeed, 
previous findings from our lab analyzing src mutations in multiple frazzled 
backgrounds found that src kinases antagonizes midline crossing in a 
Netrin/Frazzled independent fashion, suggesting src is acting on an unidentified 
parallel pathway for midline crossing (O’Donnell and Bashaw, 2013). A role for 
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p190 in midline crossing would reconcile these findings while also pointing at 
interactions that may modulate Sema-1a reverse signaling output. 
The cytoplasmic region between amino acids 31-60 of Sema-1a provides the 
binding site for Pbl and p190, but it also includes part of a putative Enabled (ena) 
binding site (LPQP).  This enabled binding site is required in the giant fiber for 
Sema-1a reverse signaling (Godenschwege 2002).  To test whether the 
requirement for this region in midline crossing was due to p190 interactions 
rather than ena, we assessed ena mutants in the screening background, and 
found that crossing defects are not enhanced in ena mutants (data not shown).  
Interestingly, the Sema-1a mediated adhesive response uncovered in the 
photoreceptors is also dependent on the down regulation of Rho1 (Hsieh et al., 
2014).  In the photoreceptors, however, the adhesive molecule FasII, which is not 
expressed in the commissural eagle neurons, ultimately mediated adhesion.  
Other adhesive molecules like integrins are also unlikely to function downstream 
of Sema-1a in the context of midline crossing, since they were previously tested 
in our lab when the p190 inhibitor, Src, was identified as an antagonist to midline 
crossing (O’Donnell and Bashaw, 2013).  The implication of p190 as a 
downstream effector in the context of Sema-1a mediated midline crossing is 
intriguing since it represents an alternative output for Sema-1a reverse signaling. 
While Pbl mediates repulsion/defasciculation and target recognition in the motor 
neurons, p190 is thought to control fasciculation by antagonizing Pbl activity. 
p190 has been shown to stabilize branches and promote adhesion in other 
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systems, but negative regulation of Rho1 may also promote attraction (Billuart et 
al., 2001; Ng and Luo, 2004; Yuan et al., 2003). With these possibilities in mind, 
it was unclear what response p190 might be mediating in the commissural 
neurons. Taken together, our findings point to a Sema-1a mechanism that is 
neither repulsive nor adhesive, leading us to explore the possibility of an 
attractive mechanism. 
The secreted Sema2s function as attractive/ adhesive ligands for Sema-
1a mediated midline crossing 
The genetic interactions we tested implicate the secreted Sema-2s as the 
potential signaling partners for Sema-1a mediated midline crossing. Sweeney et 
al. clearly demonstrate that the Sema-1a ectodomain selectively binds to tissue 
where Sema-2a is overexpressed, yet evidence for a direct physical interaction is 
still lacking (Sweeney et al., 2011). Although this interaction is unlikely to be 
direct, we show that Sema-1a requires Sema-2a to rescue midline crossing 
(Figure 2.11). Furthermore, the double mutant phenotypes with fra demonstrate 
that the secreted semaphorins are required for axons to cross the midline (Figure 
2.9 and 7). The medial expression of the secreted Sema2s, in particular Sema-
2a, suggests that they signal directional information rather than promote 
permissive adhesion. Sema-2b has indeed been shown to signal attraction in 
sensory neurons (Wu et al., 2011). We propose a model where the secreted 
Sema2s act as attractive cues to promote midline crossing as the simplest 
interpretation of the observed phenotypes.  
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Future Directions 
 
While we demonstrate a role for Sema-1a reverse signaling in pre-crossing 
commissural axons, forward signaling is important for the formation of 
longitudinal tracts post-crossing(Jeong et al., 2012; Terman and Kolodkin, 2004; 
Yang and Terman, 2012; Yu et al., 1998b). The midline, as an intermediate 
target, may offer a unique context for the shift between forward and reverse 
signaling.  Further investigation to uncover regulatory components of the Sema-
1a reverse signaling pathway would prove illuminating in understanding how 
these distinct outputs are achieved. 
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 Sema-1a Reverse Signaling Figures 
 
Figure 2.1 
 
	
 
50	
 
Figure 2.1. Sema-1a is a positive regulator of midline crossing 
(A–F) Stage 15–16 embryos of the indicated genotypes carrying eg-GAL4 and 
UAS-CD8 GFP transgenes, stained with anti-HRP (magenta) and anti-GFP 
(green) antibodies. Anti-GFP labels cell bodies and axons of the eagle neurons 
(EG and EW) in these embryos. Arrowheads indicate segments with non-
crossing EW axons and asterisks indicate rescued EW crosses. (A) EW 
neurons cross in the posterior commissure in 100% of segments in wild-type 
embryos (starred arrowhead). (B) frazzled (fra3/fra3) mutants show crossing 
defects in eagle neurons, where EW neurons fail to cross in 27% of segments 
(arrowheads). (C) Expression of a Frazzled dominant negative receptor (UAS-
Fra∆C) selectively in eagle neurons produces a Fra-like phenotype where EW 
neurons fail to cross in 32% of segments. (D) Heterozygosity of sema-1a 
dominantly enhances the EW crossing defects in a Fra∆C background to 64%. 
(E) Complete loss of sema-1a leads to further enhancement and EW neurons 
fail to cross in 99% of segments. (F) EW crossing defects in the sema-1a null 
expressing Fra∆C can be robustly rescued from 99% to 24% when a UAS 
Sema-1a transgene is expressed in eagle neurons (G) Histogram quantifies 
EW midline crossing defects in the genotypes shown in (A–F). Data are 
represented as mean+SEM. n, number of embryos scored for each genotype. 
Significance was assessed by multiple comparisons using the Student’s t-test 
(****p<0.0001). Brightness and contrast are enhanced on the GFP channel to 
make eagle neurons more visible over HRP. 
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Figure 2.2 
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Figure 2.2 Sema-1a functions in parallel to frazzled to promote midline 
crossing 
(A–F) Stage 16 embryos of the indicated genotypes stained with anti-HRP 
antibodies. Arrowheads indicate thin/defective commissures, arrows indicate 
missing commissures and asterisks indicate rescued commissures. (A) Thick 
anterior and posterior commissures are formed as axons cross the midline in 
nearly every segment. (B) frazzled (fra3/fra4) mutants show thin (29%) and 
occasionally missing commissures (10%). (C) sema-1a mutants show no 
obvious signs of commissural defects. (D) Embryos heterozygous for both 
sema-1a and fra appear wild-type. (E) Loss of sema-1a significantly worsens 
the crossing defects of Fra single mutants and fra, sema-1a double mutants 
show a 68% loss of commissures. (F) Pan-neural expression of  Sema-1a 
partially rescues these defects, and reduces missing commissures to 25%. (G) 
Histogram quantifies commissural defects as absent (black bar), thin/defective 
(dark gray) or wild-type (light grey) in the genotypes shown in (A–F). Data are 
represented as mean+SEM. n, number of embryos scored for each genotype. 
Significance was assessed by multiple comparisons using the Student’s t-test 
(****p<0.0001). See also Figure 2.1. 
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Figure 2.3 
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Figure 2.3. Sema-1a dominantly enhances the eagle crossing defects in 
both frazzled and netrinAB/B mutants. 
(A–D) Stage 16 embryos of the indicated genotypes stained with anti-HRP 
antibodies. Arrowheads indicate thin/defective commissures, arrows indicate 
missing commissures and asterisks indicate rescued commissures. (A) Thick 
anterior and posterior commissures are formed as axons cross the midline in 
nearly every segment. (B) netAB mutants show thin (20%) and missing 
commissures (5%). (C) Sema-1a mutants show no obvious signs of 
commissural defects. (D) NetAB, sema-1a double mutants show a 48% loss of 
commissures. (E) Histogram quantifies commissural defects as absent (black 
bar), thin/defective (dark gray) or wild-type (light grey) in the genotypes shown 
in (A–D). Scores for fra and fra, sema-1a double mutants are included as 
reference. Data are represented as mean+SEM. n, number of embryos scored 
for each genotype. Significance was assessed by multiple comparisons using 
the Student’s t-test  (****p<0.0001). (F) Heterozygosity for sema-1a significantly 
enhances the EW crossing defects in fra hypomorphs (fra3/fra6) to 38%. Loss of 
one copy of sema-1a also enhances crossing defects in fra single mutants 
(fra3/fra4) from 24% to 43%. EW crossing defects in NetAB mutants (34%) are 
also increased when a single copy of sema-1a is removed (50%). Data are 
represented as mean+SEM. n, number of embryos scored for each genotype. 
Significance was assessed using the Student’s t-test (**p<0.01). 
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Figure 2.4 
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Figure 2.4. Loss of sema-1a does not suppress ectopic FasII crossing 
defects or expand Robo-1 expression. 
(A–D) Stage 17 embryos of the indicated genotypes stained with the Anti-
FasciclinII (FasII) antibodies. Anti-FasII labels longitudinal tracts of ispilateral axons 
in these embryos. Arrowheads indicate segments with ectopic crossing of FasII 
axons. (A) Embryos heterozygous for slit/+ (or robo-1/+ or sema-1a/+) display 
intact longitudinals and FasII positive neurons never cross the midline. (B) sema-
1a mutants show longitudinal breaks (arrow) but FasII neurons never cross the 
midline (C) Embryos heterozygous for robo-1 and slit show ectopic crossing 
defects (33%) due to reduced repulsion from the midline (D). These ectopic 
crossing defects are not significantly suppressed when sema-1a is also mutant 
suggesting that Sema-1a does not act as a negative regulator of Robo-1 repulsion. 
(E) Histogram quantifies ectopic FasII crossing defects in the genotypes shown in 
(A–D). Data are represented as mean+SEM. n, number of embryos scored for 
each genotype. Significance was assessed by using the Student’s t-test. (F-I) 
Stage 15–16 embryos of the indicated genotype stained with anti-HRP and anti-
Robo-1 antibodies. (F) Embryos heterozygous for sema-1a exhibit the normal 
distribution of Robo-1 protein expression (G) Robo-1 is normally excluded from the 
commissural segment of axons (H) sema-1a mutant embryos do not show any 
qualitative elevation of Robo-1 protein expression (I) and Robo-1 protein is still 
restricted from commissural segments in sema-1a mutants, suggesting that Sema-
1a does not endogenously function to regulate Robo-1 protein expression at the 
midline. 
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Figure 2.5 
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Figure 2.5. Sparse labeling of Sema-1a reveals endogenous expression in 
the commissural eagle neurons 
An artificial exon knocked into the endogenous locus for sema-1a, developed in 
the Zipursky lab, allows for tissue specific labeling of endogenous Sema-1a 
expression. (A) Schematic of sparse labeling paradigm adapted from Pecot, et 
al. 2013. In the presence of a FLP recombinase, Sema-1a becomes tagged 
with a V5 epitope and LexA driven membrane bound GFP labels the full extent 
of the Sema-1a positive cells. (B-C) Early stage 15 embryo carrying the artificial 
exon, egGal4, UAS-FLP recombinase and LexAop-myrGFP. Embryo is stained 
with anti-GFP (green) and anti-V5 (magenta) antibodies. (B) Eagle neurons 
endogenously express Sema-1a during midline crossing. (C) Magnification of 
the boxed region in B. (C’) GFP only staining shows two EW axons crossing the 
midline (C’’) V5 staining reveals that Sema-1a protein is expressed throughout 
the growing axon. 
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Figure 2.6 
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Figure 2.2.6. Sema-1a can rescue midline crossing cell autonomously. 
(A–D) Stage 15–16 embryos of the indicated genotypes carrying eg-GAL4, 
UAS-Fra∆C and UAS-CD8 GFP transgenes, stained with anti-GFP (green) 
antibodies. Anti-GFP labels cell bodies and axons of the eagle neurons (EG 
and EW) in these embryos. Arrowheads indicate segments with non-crossing 
EW axons and asterisks indicate rescued EW crosses. (A) sema-1a null 
embryos expressing Fra∆C show severe crossing defects in EW neurons, 
which fail to cross the midline in 98% of abdominal, segments (arrowheads). 
(B) Expression of a full-length Sema-1a transgene in eagle neurons strongly 
rescues these defects (asterisk), with only 26% non-crossing (arrowheads). (C) 
In contrast, a Sema-1a transgene lacking a small region of the cytoplasmic 
domain (from aa31-60) significantly reduced defects to a much lesser extent 
(80%), suggesting this region is important for promoting midline crossing (D) 
Expression of a Sema-1a transgene without its cytoplasmic domain does not 
significantly rescue crossing defects and EW neurons still fail to cross in 97% of 
segments. (E) Diagram of transgenic rescue constructs (F) Histogram 
quantifies EW midline crossing defects in the genotypes shown in (A–D). Data 
are represented as mean+SEM. n, number of embryos scored for each 
genotype. Significance was assessed by multiple comparisons using the 
Student’s t-test (****p<0.0001). 
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Figure 2.7 
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Figure 2.7. The cytoplasmic domain of Sema-1a is required to promote 
midline crossing indicating Sema-1a promotes midline crossing through 
reverse signaling. 
(A–F) Stage 16 embryos of the indicated genotypes stained with anti-HRP 
antibodies. Arrowheads indicate thin/defective commissures, arrows indicate 
missing commissures and asterisks indicate rescued commissures. (A) 
Commissure formation is impaired in sema-1a, fra double mutants and 65% of 
commissures are absent. (B) Pan-neural expression of full length Sema-1a with 
elavGal4 can partially rescue crossing defects in sema-1a, fra double mutants 
reducing the number of missing commissures to 25%. (C) A Sema-1a 
transgene lacking a small region of the cytoplasmic domain (from aa31-60) 
does not rescue the midline crossing phenotype as well as wild type, 
suggesting this region is important for promoting midline crossing. (D) A Sema-
1a transgene lacking the cytoplasmic domain fails to rescue the crossing 
defects and commissure formation is not significantly different from double 
mutants. (E) Histogram quantifies commissural defects as absent (black bar), 
thin/defective (dark gray) or wild-type (light grey) in the genotypes shown in (A–
F). Data are represented as mean+SEM. n, number of embryos scored for each 
genotype. Significance was assessed by multiple comparisons using the 
Student’s t-test (****p<0.0001). 
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Figure 2.8 
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Figure 2.8 RhoGAPp190, but not Pebble, significantly enhances crossing 
defects in the Fra∆C background 
Histogram quantifies EW midline crossing defects in the Fra∆C screening 
background. Heterozygosity for RhoGAPp190 does not show a significant 
enhancement in crossing defects, however, RhoGAPp190 nulls do strongly 
enhance these defects (81%). pebble heterozygotes significantly suppressed 
these defects (10%). In addition, heterozygosity for rho1 or expression of a 
Rho1 dominant negative also suppress the Fra∆C phenotype. Data are 
represented as mean+SEM. n, number of embryos scored for each genotype. 
Significance was assessed by multiple comparisons using the Student’s t-test 
(****p<0.0001, ***p<0.001, **p<0.01, *p<0.05). (B) Model of functional 
responses of Sema-1a reverse signaling through its downstream effectors.  
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Figure 2.9.  
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Figure 2.9. Sema-2a significantly enhances crossing defects in 
frazzled mutants while plexins do not 
(A–F) Stage 16 embryos of the indicated genotypes stained with anti-HRP 
antibodies. Arrowheads indicate thin/defective commissures and arrows 
indicate missing commissures. (A) fra (fra3/fra4) mutants show thin (10%) and 
occasionally missing commissures (29%). (B) fra; plexinA 
(plexAEY16548/plexAEY16548) double mutants resemble fra single mutants with 
12% absent, 32% thin/defective and 54% wild-type commissures. (C) fra; plexin 
B (plexBKG00878/plexBKG00878) double mutants also show no significant 
enhancement of the fra single mutants with 16% absent, 35% thin/defective 
and 49% wild-type commissures. (D) Embryos mutant for sema-1a and fra 
display severe commissural defects. (E) Loss of sema-2a significantly worsens 
the crossing defects of fra single mutants with 24% absent, 52% thin/defective 
and only 24% wild-type commissures. (F) Triple mutants lacking fra, sema2a 
and sema-2b are not significantly different from the fra, sema-2a double 
mutants (G) Histogram quantifies commissural defects as absent (black bar), 
thin/defective (dark gray) or wild-type (light grey) in the genotypes shown in (A–
F). Data are represented as mean+SEM. n, number of embryos scored for each 
genotype. Significance was assessed by multiple comparisons using the 
Student’s t-test(****p<0.0001). 
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Figure 2.10 
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Figure 2.10. The secreted sema-2s enhance crossing defects in fra 
mutants 
(A–D) Stage 15–16 embryos of the indicated genotypes carrying eg-GAL4, and 
UAS-taumycGFP transgenes, stained with anti-GFP antibodies. Anti-GFP 
labels cell bodies and axons of the eagle neurons (EG and EW) in these 
embryos. Arrowheads indicate segments with non-crossing EW axons. (A) fra, 
sema-1a double mutants display strong EW crossing defects (arrowheads 
97%). (B) Embryos mutant for both fra and sema-2a show increased crossing 
defects (75%) when compared to fra single mutants. (C) fra, sema-2b double 
mutants also show a significant increase in EW crossing defects (50%) 
suggesting sema-2b also promotes midline crossing. (D) Triple mutants exhibit 
elevated EW crossing defects (58%). (F) Histogram quantifies EW midline 
crossing defects in the genotypes shown in (A–D). Data are represented as 
mean+SEM. n, number of embryos scored for each genotype. Significance was 
assessed by multiple comparisons using the Student’s t-test (****p<0.0001, 
***p<0.001). 
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Figure 2.11 
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Figure 2.11 Sema-2a is required for Sema-1a mediated midline crossing 
(A) Histogram quantifies EW midline crossing defects in sema-1a null mutants 
carrying the transgenes for egGal4 and UAS-Fra∆C. This background shows 
strong EW crossing defects (97%) that can be rescue cell autonomously when 
full length Sema-1a is expressed selectively in eagle neurons (33%). In the 
absence of plexA this rescue is not significantly reduced (43%). However, loss 
of sema-2a significantly suppresses this rescue and embryos still exhibit severe 
crossing defects (63%) suggesting that sema-2a is required for sema-1a 
mediated midline crossing. Data are represented as mean+SEM. n, number of 
embryos scored for each genotype. Significance was assessed by multiple 
comparisons using the Student’s t-test (**p<0.01). (B) Model of Sema-1a 
mediated midline crossing. 
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CHAPTER 3: CONCLUSIONS AND FUTURE DIRECTIONS 
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3.1 Introduction 
	
This work has demonstrated that Sema-1a reverse signaling is a novel pathway 
for promoting midline crossing. Yet many questions still remain. First, I will 
discuss the main conclusions and the broad reaching questions that we hope to 
work towards answering. Next, I will outline outstanding questions and the 
experiments underway to address them. With future experiments we hope to 
shed light on what intrinsic and extrinsic factors regulate the distinct outputs of 
Sema-1a reverse signaling generated in each biological context. With more 
information we hope to better understand how similar pathways impinge on each 
other to promote discreet outputs. As semaphorin signaling has been implicated 
in a number of diseases this detailed understanding may help develop therapies 
targeted at specific semaphorin signaling cascades that influence cancer, 
immune system dysfunction or nerve regeneration. 
 
3.2 Additional Pathways for Midline Crossing 
 
We have found that Sema-1a reverse signaling is independent of Netrin/Frazzled 
chemoattraction and represents a novel pathway to promote midline crossing. 
We were able to uncover this alternative pathway through a very targeted 
approach in a sensitized background. We hope to uncover still more pathways 
through continued screening; however, this screen is labor intensive and there 
are limitations to its sensitivity. Sema-1a was an unlikely candidate since sema-
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1a mutants lacked any overt defects in midline crossing. It is very likely that 
additional alternative pathways will harbor ever more subtle phenotypes. For 
such a fundamental aspect of development, it is not surprising that there would 
be multiple layers of redundancy. It is unclear how many different pathways may 
be contributing to midline crossing and if they act in discrete cell types. 
Therefore, it would be beneficial to develop new tools that allow more precise 
control at these early stages of development. Many of the high resolution sparse 
labeling techniques used later in development are inadequate for embryonic 
investigations. Large-scale generation of promoter based Gal4 lines are 
underway and these will prove to be instrumental in the future. Our screen has 
identified a number of genes on chromosome two, but an adapted version has 
been initiated on chromosome three. Hopefully we will be able to fill in the gaps 
in our knowledge for existing pathways while also discovering new pro-crossing 
pathways. With this knowledge, we can ultimately work towards understanding 
how multiple signaling cascades are integrated to mediate axonal responses. 
 
3.3 Sema Reverse Signaling: More common than we think? 
	
Sema-1a, Frazzled double mutants reveal strong commissural defects that would 
suggest the Sema-1a reverse signaling is broadly used to promote midline 
crossing; Sema-1a is also expressed by a large population of neurons within the 
CNS. Taken together, it is tempting to speculate that Sema-1a reverse signaling 
is acting in all commissural neurons to promote crossing. In contrast, Sema-1a 
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single mutants display no gross defects in commissure formation. Could this 
signaling pathway be restricted to a specific subset of pioneering neurons? 
Ablation studies suggested that Sema-1a positive neurons could be classified 
into two large subsets: the HB9+ motor neurons and the GAD+ Gabaergic 
interneurons. Considering the motor neurons utilize Sema-1a forward and 
reverse signaling later in pathfinding, it would be easy to presume they also use it 
to cross the midline. It would be interesting to see if there is a commissural defect 
in Sema-1a mutants when examining either of these selective neuronal subsets. 
Notably, the eagle interneurons used through out this study are serotonergic 
interneurons that we empirically determined to be Sema-1a positive, therefore 
these ablation studies are not exhaustive and likely reflect those neural 
populations that express the highest levels of Sema-1a. Understanding which 
cells require Sema-1a reverse signaling for crossing and are sensitive to the loss 
of Sema-1a would help identify intrinsic properties that allow for Sema-1a reverse 
signaling and the regulation of its distinct outputs. Furthermore, the ability to 
target semaphorin reverse signaling specifically will make it easier to address 
whether this pathway is conserved in the vertebrate midline. The midline may be 
one of many tissues where Sema-1a reverse signaling is masked in some way. 
The clearest examples of Sema-1a reverse signaling have been identified with 
single cell resolution. Taken together, this may suggest that more careful 
examination will be required to capture the full extent of Sema-1a reverse 
signaling in other systems. 
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3.4 Regulating	Distinct Forward and Reverse Signaling pathways  
 
We were able to identify a context where Sema-1a forward signaling and reverse 
signaling we clearly separated. However, it is unclear how this separation is 
regulated and what changes may occur upon reaching the midline. Vertebrate 
literature suggests that Sema/Plexin forward signaling is important post-crossing 
and Plexin is highly regulated to prevent premature signaling; perhaps, this is 
also true in Drosophila (Charoy et al., 2012; Nawabi et al., 2010; Zou et al., 
2000). It is possible that Sema-1a reverse signaling occurs independently from 
forward signaling only because there are other mechanisms for silencing forward 
signaling until after crossing the midline. A number of negative regulators for 
Sema-1a forward signaling have already been identified (Terman and Kolodkin, 
2004; Yang and Terman, 2012). This might also suggest that Sema-1a reverse 
signaling might be modified upon crossing, as Plexins may no longer be 
negatively regulated. As an intermediate target the midline offers an opportunity 
for changes in responsiveness and it would be very interesting to test further how 
Sema-1a reverse signaling informs axons to change their responses at the 
midline. According to findings in the chick spinal cord, semaphorin reverse 
signaling is also important for post-crossing navigation, through Sema6B and its 
PlexinA receptors (Plexa2 and PlexA4) (Andermatt et al., 2014). This would imply 
that forward and reverse signaling may function simultaneously when they 
produce the same response much like they do during heart chamber 
development (Toyofuku et al., 2004b) or in Drosophila motor neurons (Jeong et 
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al., 2012).  It will be very illuminating if future studies could decipher how forward 
and reverse signaling pathways are segregated and/or integrated. Some insights 
are available from the Eph/Ephrin or Tumor Necrosis Factor (TNF) signaling 
pathways that are also known to function bi-directionally (Davy and Soriano, 
2005; Eissner et al., 2004). It would be interesting if any of the mechanisms 
identified in these bidirectional pathways also apply to Sema/Plexin signaling. 
Futile cis interactions between Sema/Plexin have already been uncovered in the 
hippocampus (Suto et al., 2007) and dorsal root ganglion(Haklai-Topper et al., 
2010). Perhaps subcellular localization to lipid rafts, which has been identified in 
Eph/Ephrin signaling, will also be important for Sema/Plexin bi-directional 
signaling. 
 
3.5	Future Directions 
	
Identify components of the ligand and receptor complex 
Although semaphorins traditionally bind plexin receptors there are a number of 
documented cases where semaphorins bind other proteins. We have found that 
Sema-1a meditates its midline crossing functions through a non-canonical 
signaling partner, the secreted Sema-2s. This interaction has been previously 
identified in the olfactory system where it was found to prepattern the olfactory 
bulb (Sweeney et al., 2011). This binding is likely to be indirect since direct 
physical interactions could not be demonstrated. The interaction between Sema-
1a and the Sema-2s may involve an intermediate protein to act as an adaptor or 
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co-receptor. It is clear that purified Sema-1a ectodomain can bind to tissue, both 
neuronal and non-neuronal, when misexpressing secreted or membrane-tethered 
Sema-2a (Sweeney et al., 2011).   The fact that the Sema-1a ectodomain was 
purified suggests that any intermediate protein is less likely to act as a co-
receptor in cis and more likely to function in trans. Further, the evidence that 
binding can occur in vivo in multiple tissues suggest that the intermediates 
should be broadly expressed and are not strictly neuronal. To identify potential 
intermediates we could perform co-immunoprecipitation experiments with embryo 
lysates from embryos expressing a tagged Sema-1a in eagle neurons. Proteins 
could be identified though mass spectroscopy and physical interactions validated 
through cell overlay assays. These proteins would then be tested for genetic 
interactions in the screening background and with frazzled mutants. 
In the olfactory system, Sema-1a reverse signaling produces a repulsive 
response while an attractive response best reconciles our findings.  How could 
the same receptor-ligand pair produce differing outputs? There may be more 
than one intermediate that can influence the directional output similar to what is 
found with Sema5A and Heparin Sulfate Proteoglycans (HSPGs) or Chondroitin 
Sulfate Proteoglycans (CSPGs). Sema5A induces an attractive response when 
bound to HSPGs while CSPG binding induces a repulsive response (Kantor et 
al., 2004). In fact, Syndecan, an HSPG found in the Drosophila ventral nerve 
cord, has also been identified in our screen to promote midline crossing. 
Syndecan is also required for correct photoreceptor targeting and shows defects 
that resemble Sema-1a in the retina (Rawson et al., 2005). This is compelling 
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since these defects are attributed to Sema-1a reverse signaling, yet Plexin A is 
the functional ligand in this context (Cafferty et al., 2006; Hsieh et al., 2014; Yu et 
al., 2010). Additionally, Perlecan, a secreted HSPG, has been found to facilitate 
Sema-1a forward signaling in motor neurons (Cho et al., 2012).  Initial attempts 
to analyze syndecan, frazzled double mutants revealed no significant 
enhancement of overall commissural defects (data not shown).  However, these 
embryos we not evaluated specifically in the eagle neurons, which is more 
sensitive and quantifiable. Considering, our findings with Sema-2b, this might 
prove more informative and may warrant re-examination. Furthermore, it is 
possible that there is compensation from other HSPGs so these should also be 
tested in the screening background and in combination with Syndecan.  
 
Determine factors regulating Sema-1a signaling 
Sema-1a reverse signaling has been demonstrated to produce multiple signaling 
outputs and it is unknown how these conflicting responses are regulated. The 
ability for Sema-1a to bind and signal through effectors that regulate Rho1 in 
opposing ways demonstrates how this might be accomplished. However, it is 
unclear how it is determined which effector is functional at which time. The Src 
family kinases were previously identified as negative regulators of commissural 
guidance (O’Donnell and Bashaw, 2013).  Interesting this src function is 
independent of Netrin/Frazzled chemoattraction and thus, must be negatively 
regulating a parallel pathway for midline crossing.  The Sema-1a reverse 
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signaling pathway we uncovered is a very likely candidate. Src is a highly 
conserved negative regulator of RhoGAPp190 (Brouns et al., 2001; Roof et al., 
2000) . This would be consistent with a model where Src antagonizes midline 
crossing by negatively regulating Sema-1a reverse signaling through 
phosphorylation of RhoGAPp190. We have started to test this model genetically 
by evaluating src mutants in the screening background where they have been 
found to suppress crossing defects. We have also found that heterozygosity for 
src suppresses defects in frazzled hypomorphs, but not when sema-1a is mutant. 
This would indicate that the suppressive effect of src loss of function is 
dependent on Sema-1a. This experiment will be more convincing if repeated with 
complete loss of src. In the future we would like to build upon these observations 
and test if loss of src enhances the ability for Sema-1a to rescue midline 
crossing. Also, a direct interaction with Src and RhoGAPp190 in the eagle 
neurons should be demonstrated biochemically. We have demonstrated that 
overexpression of RhoGAP190 can rescue crossing defects in the screening 
background, but we would like to test if a better rescue is achieved with a 
variation of RhoGAPp190 that cannot be phosphorylated by src.  In addition, 
another gene that was identified through the screen, brain tumor (brat), 
negatively regulates Src by sequestering src mRNA (Marchetti et al., 2014).  This 
further supports the notion that Src antagonizes midline crossing and needs to be 
negatively regulated in order to promote crossing. Moreover, this type of 
regulation allows for tight temporal and spatial control, which might explain how 
Sema-1a reverse signaling might be compartmentalized within a neuron. 
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Determining Distinct Signaling Outputs  
We have constructed a model of Sema-1a reverse signaling at the midline that 
suggests attraction to the midline in response to Sema2s. We cannot rule out 
adhesion, which is also a common outcome of RhoGAPp190. We would ideally 
be able to assay the Sema-1a mediated response in a more direct manner. We 
initially attempted misexpression of Sema-2s from different sources around eagle 
neurons in order to identify a response within eagle neurons, but this failed to 
produce any phenotype. This is likely do to the fact that Sema-1a reverse 
signaling is best targeted when Netrin/Frazzled signaling is also reduced. We 
would like to repeat these experiments in a frazzled heterozygous or 
hypomorphic background.  
In order to discern the necessary source of the Sema-2s, we are currently trying 
to establish a rescue assay. Expression of UAS-Sema-2a should be able to 
rescue the crossing defects in the frazzled, sema-2a double mutant, at least 
partially. In this way we hope to determine whether Sema-2a is functioning in a 
directional or permissive manner. If our model is correct, and Sema-2a functions 
to promote crossing through attraction to the midline then crossing defects 
should be rescued when Sema-2a is expressed in the midline glia. However, 
pan-neural expression should be able to rescue crossing if Sema-2a is 
functioning as a permissive/non-instructive cue. 
Although an in vivo assay for functional responses would be ideal, an in vitro 
approach would also provide valuable insights. The combination of Drosophila’s 
genetic tools with primary cell culture would allow us to assay functional 
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responses to purified proteins at specified locations and concentrations. There 
has been much progress in developing a system to culture primary Drosophila 
neurons (Bai et al., 2009; Küppers-Munther et al., 2004; Prokop and Küppers-
munther, 2012). Coupled with the advances in nanofabrication for microfluidic 
devices and microcontact printing, axonal responses can be assayed directly 
(Dupin et al., 2013; Lang et al., 2008; Millet and Gillette, 2012; von Philipsborn et 
al., 2006).  To better understand the Sema-1a mechanism for midline crossing in 
eagle neurons and how reverse signaling changes outputs in different contexts, 
we would like to establish a primary culture assay. This method would allow us to 
determine how eagle neurons respond to a direct source of Sema-2a. This is a 
major undertaking and we are currently still experimenting with culturing 
conditions.  
In conclusion, future studies are needed to further the understanding of the 
molecular components of the Sema-1a reverse signaling pathway in the context 
of midline crossing and in other systems. Uncovering the mechanisms leading to 
such diverse signaling outputs will also advance the knowledge of axon guidance 
as a whole. 
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